Tech Company Financing Transactions

Acylin Therapeutics Funding Round

On 6/30/2011, Acylin Therapeutics raised $2.4 million in funding from Allegis Capital, Amgen Ventures and Arch Venture Partners.

Transaction Overview

Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$2,399,900
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. 203
Seattle, WA 98102
USA
Website
Email Address
Not Recorded
Overview
Acylin Therapeutics is the first company focused on developing inhibitors of cellular acetylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and neurodegeneration.
Profile
Acylin Therapeutics LinkedIn Company Profile
Social Media
Acylin Therapeutics Company Twitter Account
Company News
Acylin Therapeutics News
Facebook
Acylin Therapeutics on Facebook
YouTube
Acylin Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Founder
Suresh Jain
  Suresh Jain LinkedIn Profile  Suresh Jain Twitter Account  Suresh Jain News  Suresh Jain on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2011: Looxcie venture capital transaction
Next: 6/30/2011: Spectra Analysis venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary